Cytokinetics, Incorporated logo
Cytokinetics, Incorporated CYTK
€ 37.20 -6.95%

Geschäftsbericht 2024
hinzugefügt 27.02.2025

report update icon

Cytokinetics, Incorporated Kennzahlen 2011-2025 | CYTK

Kennzahlen Jährlich Cytokinetics, Incorporated

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -0.0 -0.0 -0.0 -6.1 -3.6 -3.6 24.4 -8.0 -17.3 -6.5 -3.0 -1.5

P/S

0.3 0.9 0.0 0.0 0.0 27.6 12.0 34.0 3.8 10.4 5.4 7.1 15.8 18.4

EPS

-5.3 -5.5 -4.3 -2.8 -2.0 -2.1 -1.9 -2.6 0.4 -1.0 -0.4 -1.2 -2.3 -0.7

EV (Enterprise Value)

1.45 B 1.1 B 1.06 B 488 M 339 M 1 B 521 M 514 M 410 M 280 M 274 M 228 M 112 M 59.4 M

EBITDA per Share

-4.7 K -5.02 K -3.54 K -2.39 K -1.43 K -1.69 -1.61 -2.26 0.486 -0.949 -0.399 -1.23 -2.2 -3.85

EV/EBITDA

-2.7 -14.4 -8.5 -4.3 -3.2 18.8 -6.7 -16.3 -5.9 -2.6 -1.2

PEG

-0.0 -0.0 -0.0 -0.0 -0.0 0.74 -0.14 0.0 0.17 0.06 -0.26 -0.15 -0.06 -0.24

P/B

-0.0 -0.0 -0.0 0.0 0.0 -67.7 14.6 4.1 4.3 4.4 2.8 4.0 1.7 1.5

P/CF

-0.0 -0.0 -0.0 -0.0 0.1 -7.9 -3.7 -4.3 11.3 69.2 -5.5 -26.5 -3.6 -1.6

ROE %

435.49 136.22 360.48 -88.29 -112.27 1112.66 -409.84 -116.34 17.44 -54.67 -15.91 -61.93 -57.60 -99.34

ROA %

-42.06 -63.84 -38.33 -25.59 -23.85 -41.99 -50.33 -43.35 9.67 -32.54 -11.01 -40.53 -52.06 -90.69

ROCE %

396.13 128.44 300.47 -76.40 -82.85 -37.48 -47.05 -43.22 13.65 -44.75 -13.52 -60.01 -57.51 -97.08

Current Ratio

0.9 0.7 0.9 1.4 1.3 9.0 9.4 8.5 4.8 3.6 5.5 3.0 10.8 11.1

DSO

177.2 34.7 100.3 145.7 31.3 70.1 78.6 30.4 0.1 0.2 362.7 0.1 0.2 1.3

DIO

- - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - -

Betriebszyklus

177.2 34.7 100.3 145.7 31.3 - - - - - - - - -

Finanzkreislauf

177.2 34.7 100.3 145.7 31.3 - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Cytokinetics, Incorporated

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.36 -1.31 -1.35 -1.34 -1.38 - -1.52 -0.23 -1.05 - -0.95 -0.86 -0.66 - -0.05 -0.68 -0.66 - -0.5 -0.56 -0.54 - -0.4 -0.51 -0.56 - -0.6 -0.6 -0.62 0.18 0.84 -0.29 -0.31 - -0.23 -0.27 -0.23 - -0.16 -0.23 -0.27 0.22 -0.43 -0.58 -0.53 - -0.45 -0.76 -0.13 - -0.15 -0.23 -0.18

EBITDA per Share

- - - - -1.29 K - -1.11 K -127 -900 - -842 -764 -563 - 95.8 -529 -505 - -393 -454 -442 - -0.3 -0.41 -0.47 - -0.5 -0.5 -0.55 - 0.86 -0.27 -0.3 - -0.22 -0.27 -0.23 - -0.15 -0.22 -0.26 - -0.42 -0.58 -0.52 - -0.43 -0.64 -0.13 - -0.13 -0.18 -0.15

ROE %

1090.17 -6.59 1016.16 1877.38 1820.97 795.99 765.44 -155.83 -511.35 -473.29 -476.09 -448.33 -110.99 -73.52 196.87 470.07 799.65 832.51 747.62 392.33 -7.42 -307.79 -344.64 -289.20 -209.55 -116.34 -71.90 -7.08 7.09 17.44 -3.60 -51.86 -54.94 -54.67 -32.05 -25.63 -19.35 -15.91 -13.08 -29.72 -48.25 -61.93 -90.27 -81.48 -66.61 -57.60 -65.91 -73.66 -89.20 -99.34 -22.08 -28.30 -24.31

ROA %

-54.55 -58.13 -61.95 -57.70 -51.65 -34.12 -43.31 -28.83 -39.74 -28.26 -28.86 -20.26 -16.99 -15.62 -25.82 -35.43 -38.87 -31.42 -41.84 -42.06 -44.02 -37.80 -51.53 -52.08 -48.91 -43.35 -25.41 5.18 8.22 9.67 -2.55 -29.83 -32.16 -32.54 -18.18 -15.00 -12.14 -11.01 -9.51 -20.15 -31.94 -40.53 -63.15 -60.97 -54.42 -52.06 -59.79 -67.00 -81.30 -90.69 -20.16 -25.83 -22.19

ROCE %

956.74 -1.07 797.58 1448.45 1402.05 602.00 574.22 -132.31 -454.87 -419.97 -415.40 -383.04 -79.25 -50.74 168.03 382.23 655.04 687.22 618.14 330.30 -4.26 -260.11 -285.99 -242.79 -175.45 -69.98 -33.99 27.89 39.15 11.66 -1.30 -50.25 -54.02 -41.39 -47.90 -41.46 -35.15 -25.17 -48.34 -64.99 -83.53 -74.07 -88.44 -79.65 -64.75 -41.33 -63.48 -71.25 -86.79 -74.86 -22.14 -28.33 -24.39

Current Ratio

1.0 1.1 0.6 0.7 0.8 0.9 1.0 - 1.2 1.4 1.4 1.0 1.1 1.3 1.3 1.3 1.3 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.6 1.6 1.6 1.6 2.2 2.2 2.2 2.2 2.5 2.5 2.5 2.5 3.2 3.2 3.2 3.2 2.9 2.9 2.9 2.9 10.4 10.4 10.4 10.4 11.5 11.5 11.5 11.5

DSO

- - 420.5 104.8 11.4 - 41.6 3.1 2300.1 - 28.1 115.8 62.2 - 9.7 112.2 114.3 - 77.8 66.0 39.9 - 19.1 32.8 28.9 -5637.2 16.4 33.2 12.5 0.1 0.0 0.2 1.1 0.9 - - 1.1 0.2 - - 1.2 0.4 - - 10.4 3.9 - - 5.2 12.4 - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - 420.5 104.8 11.4 - 41.6 3.1 2300.1 - 28.1 115.8 62.2 - 9.7 112.2 114.3 - 77.8 66.0 39.9 - 19.1 32.8 28.9 -5637.2 16.4 33.2 12.5 0.1 0.0 0.2 1.1 0.9 - - 1.1 0.2 - - 1.2 0.4 - - 10.4 3.9 - - 5.2 12.4 - - -

Finanzkreislauf

- - 420.5 104.8 11.4 - 41.6 3.1 2300.1 - 28.1 115.8 62.2 - 9.7 112.2 114.3 - 77.8 66.0 39.9 - 19.1 32.8 28.9 -5637.2 16.4 33.2 12.5 0.1 0.0 0.2 1.1 0.9 - - 1.1 0.2 - - 1.2 0.4 - - 10.4 3.9 - - 5.2 12.4 - - -

Alle Zahlen in USD-Währung